Medtronic draws subpoena
This article was originally published in The Gray Sheet
Executive Summary
Documents relating to the firm's cardiac rhythm management devices are subpoenaed by the Office of Inspector General for the Department of Health and Human Services in the district of California, Medtronic discloses in a quarterly financial report filed Dec. 9 with the Securities and Exchange Commission. Related documents include "revenue, sales, marketing and promotional documents, documents relating to reimbursement communications to customers pertaining to the devices, documents relating to scientific studies and registries pertaining to the devices, and documents relating to payments or items of value provided to customers," Medtronic explains. The firm says it will comply with the subpoena, which it received on Sept. 16. Medtronic received a separate subpoena in June from the New Jersey attorney general's office as part of an investigation into industry ties to clinical trial investigators (1"The Gray Sheet" Aug. 10, 2009)
You may also be interested in...
New Jersey AG's Targets: J&J/DePuy, Biomet, Stryker, Medtronic And...
Johnson & Johnson/DePuy is the latest of four orthopedic device makers to acknowledge receipt of a subpoena from the New Jersey attorney general's office as part of an investigation into industry ties to clinical trial investigators
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.